CellmAbs

CheckmAb

This biotechnology company develops monoclonal antibody therapies for cancer and autoimmune disease patients by targeting regulatory T cells within pathological tissues.

Arch Oncology

This biotechnology firm develops antibody therapies to treat patients with solid tumours and hematologic malignancies.

Captain T Cell

The company develops cell therapies for cancer patients to treat solid tumours.

Tacalyx

This company develops antibody-based therapeutics targeting tumour associated carbohydrate antigens for the treatment of solid tumours in cancer patients.

cCAM Biotherapeutics

The company develops monoclonal antibody immunotherapies to treat cancer patients with advanced or recurrent malignancies.

Adaptam Therapeutics

Adaptam Therapeutics develops antibody-based therapies for solid tumours to treat oncology patients by targeting immunosuppressive myeloid cells.

PanCancerT

This biotech company develops T-cell receptor therapies for patients with solid tumours, focusing on targets like triple-negative breast cancer and melanoma.

Solu Therapeutics

This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.